Download Introducing the Journal of Ophthalmic Diseases

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
http://elynsgroup.com
Copyright: © 2015 Paolo Melillo
Journal of Ophthalmic Diseases
Editorial
Open Access
Introducing the Journal of Ophthalmic Diseases
Paolo Melillo
Multidisciplinary Department of Medical, Surgical and Dental Sciences of the Second University of Naples, Italy
Received Date: December 09, 2015, Accepted Date: December 10, 2015, Published Date: December 14, 2015.
*Corresponding author: Paolo Melillo, Multidisciplinary Department of Medical, Surgical and Dental Sciences of the Second University of Naples, Italy,
E-mail: [email protected]
We are pleased to announce this inaugural issue of the Journal
of Ophthalmic Diseases (JOD). Elyns publishing group created JOD
to address the need to disseminate innovative research in the field
of ophthalmology, particularly, on topics related to physiology of
eye, eye infections and disorders, diagnostic procedures, treatment
and prevention. The journal’s aim is to provide reliable information
on current research and developments in field of ophthalmology.
We intend for JOD to provide a vehicle for basic and clinical
researchers, ophthalmologists, optometrists, technicians and other
health operators involved in the field of vision, to share the most
up-to-date scientific evidences achieved by the research in the field
of ophthalmology. The JOD could disseminate all kind of medical
research:
• Basic research, for example, genetic studies aimed at
understanding the cause of genetic ocular diseases,
development of novel diagnostic and therapeutic methods
for ophthalmic diseases, animal and cell studies to evaluate
pre-clinically the safety and potential efficacy of new
treatment for ocular pathology.
• Clinical research, such as interventional and observation
clinical studies, including report of randomized clinical
trials, prognostic or diagnostic study, observational study,
case series and single case report;
• Epidemiological research, such as case control study, cross-
sectional study, description with registry data, regarding
ophthalmic diseases.
We are strongly interested in translation research, which
is the critical step to take innovation (e.g., new drugs but also
technological advances) from the laboratories into the clinical
environment, particularly, eye clinic and surgical theatre, to improve
clinical practice and healthcare. Nowadays the most innovation in
the field of ophthalmology are related to the improvement in the
technology, e.g., the adoption of multimodal imaging techniques,
the advances in widely adopted methods, such as the angiography
by Optical Coherence Tomography. Moreover, the basic research,
particularly in genetics and molecular biology, could provide more
insight in the knowledge of disease, particularly, the inherited
ocular pathology, and lead the way to innovative strategies of care
for previously incurables blindness. Finally, also submissions of the
so-called secondary data studies, such as mini-review and reviews,
particularly, systematic and meta-analysis, will be considered.
We have a stellar editorial board of associate editors, with wide
research interests, covering almost all the most relevant research
fields in ophthalmology, ranging from biophysics, pure and applied
human visual psychophysics, to cornea and refractive surgery, from
anterior segment surgery to ophthalmic clinical and epidemiological
research, from translation research to multidisciplinary disciplines,
such as neurophthalmology. We will ask each of the associate
editors to present him / her by writing an editorial for the next
issues of the journal in order to describe the research field of his
/ her interest.
We are proud to introduce JOD with an open-source, continuouspublication platform that allows multimedia presentation of
clinically significant research. The papers published in JOD are
accessible (5-6 days after acceptance) through the Elyns Group
web sites, as well as in downloadable PDF versions with additional
material. As a peer-reviewed journal, we aimed at quick review
process (14 days) without sacrificing high standards of the
published papers. We know that the authors and readers need an
efficient and timely review. We have and will maintain the highest
standards in the review process and publication of papers. Articles
should be within the scope of the journal and describing innovative
research. We welcome submissions from academy, health providers,
industry, and policy makers. We encourage you to have your voice
heard in the social networks (e.g., Facebook, Google+, Twitter), as
suggested by the “Follow us” section of the Journal website.
*Corresponding author: Paolo Melillo, Multidisciplinary Department of Medical, Surgical and Dental Sciences of the Second University of Naples,
Italy, E-mail: [email protected]
Received Date: December 09, 2015, Accepted Date: December 10, 2015, Published Date: December 14, 2015.
Copyright: © 2015 Paolo Melillo. This is an open access article distributed under the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citation: Melillo P (2015) Introducing the Journal of Ophthalmic Diseases. J Ophth Dis 1(1): 102e.
Elyns Publishing Group
Explore and Expand
J Ophth Dis
Page 1 of 1